{"id":"NCT01663363","sponsor":"Abbott Medical Optics","briefTitle":"Safety and Effectiveness of Wavefront-Guided LASIK Corrections of Myopic Refractive Errors","officialTitle":"A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Myopic Refractive Errors With the iDesign Advanced Wavescan Studio™ System and Star S4IR™ Excimer Laser","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2014-03","completion":"2015-07","firstPosted":"2012-08-13","resultsPosted":"2015-06-26","lastUpdate":"2025-02-04"},"enrollment":170,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Myopia"],"interventions":[{"type":"DEVICE","name":"LASIK correction of myopic refractive errors","otherNames":[]}],"arms":[{"label":"wavefront-guided LASIK","type":"EXPERIMENTAL"}],"summary":"The purpose of this clinical trial is to demonstrate that wavefront-guided LASIK is safe and effective for the correction of myopic refractive errors.","primaryOutcome":{"measure":"Percentage of Eyes With Loss of More Than 2 Lines Best Spectacle Corrected Visual Acuity (BSCVA)","timeFrame":"6 Months","effectByArm":[{"arm":"Wavefront-guided LASIK","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":334},"commonTop":[]}}